Release Date: 30/07/21 08:29 Summary: Quarterly Activities/Appendix 4C Cash Flow Report Price Sensitive: No Download Document 843.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%